Effects of Sorbitol on the Pharmacokinetics of Lamivudine Solution and the FDA's Decision to Increase the Dose of Lamivudine Solution for Pediatric Patients-Reference-Cited by-同舟云学术

Effects of Sorbitol on the Pharmacokinetics of Lamivudine Solution and the FDA's Decision to Increase the Dose of Lamivudine Solution for Pediatric Patients

Published:2018-08-06 Issue:5 Volume:104 Page:785-787
ISSN:0009-9236
Container-title:Clinical Pharmacology & Therapeutics
language:en
Short-container-title:Clin. Pharmacol. Ther.

Author:

Choi Su-Young¹,Viswanathan Prabha²,Sherwat Adam²,Seo Shirley K.¹

Affiliation:

1. Division of Clinical Pharmacology IV; Office of Clinical Pharmacology; Office of Translational Sciences; Center for Drug Evaluation and Research; US Food and Drug Administration; Silver Spring Maryland USA

2. Division of Antiviral Products; Office of Antimicrobial Products; Office of New Drugs; Center for Drug Evaluation and Research; US Food and Drug Administration; Silver Spring Maryland USA

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/cpt.1147/fullpdf

Reference10 articles.

1. Effect of sorbitol on the pharmacokinetic profile of lamivudine oral solution in adults: an open-label, randomized study;Adkison;Clin. Pharmacol. Ther.,2018

2. Plasma pharmacokinetics of once- versus twice-daily lamivudine and abacavir: simplification of combination treatment in HIV-1-infected children (PENTA-13);Bergshoeff;Antivir. Ther.,2005

3. Dose evaluation of lamivudine in human immunodeficiency virus-infected children aged 5 months to 18 years based on a population pharmacokinetic analysis;Janssen;Br. J. Clin. Pharmacol.,2017

4. Age-dependent pharmacokinetics of lamivudine in HIV-infected children;Burger;Clin. Pharmacol. Ther.,2007

5. A chewable pediatric fixed-dose combination tablet of stavudine, lamivudine, and nevirapine: pharmacokinetics and safety compared with the individual liquid formulations in human immunodeficiency virus-infected children in Thailand;Vanprapar;Pediatr. Infect. Dis. J.,2010

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Potential pharmacokinetic interaction between orally administered drug and osmotically active excipients in pediatric polypharmacy;European Journal of Pharmaceutical Sciences;2021-10

2. Drug–drug interactions of a two-drug regimen of dolutegravir and lamivudine for HIV treatment;Expert Opinion on Drug Metabolism & Toxicology;2019-02-11